Synthetic Biologics awarded new patent

|About: Synthetic Biologics, Inc. (SYN)|By:, SA News Editor

Synthetic Biologics (SYN) gets patent 8,658,627 entitled Pregnancy Hormone Combination for Treatment of Autoimmune Diseases. The patent includes claims to the use of Trimesta (oral estriol) in conjunction with gestagen for the treatment of MS and other autoimmune diseases.

The company currently holds two other patents (8,372,826 and 6,936,599) covering the use of Trimesta.

17 mutual funds have positions in the stock, up from 9 a year earlier.